Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

NCT00323804 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

372

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis C, Chronic
Liver Fibrosis

Interventions

BIOLOGICAL: Peginterferon alfa-2b
DRUG: Ribavirin
DRUG: Ribavirin-Placebo

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]